https://www.selleckchem.com/pr....oducts/eribulin-mesy
To identify patterns of therapy failure after radiotherapy in Chinese patients with locally advanced cervical cancer (LACC). A retrospective study was conducted at a Chinese hospital from June 2012 to July 2018. All analyses were done using SPSS 26. 105 patients with treatment failure were included. After a median follow-up of 27 months (range 10-82), the 3-year survival rate after therapy failure was 19.4%. In multivariate analysis, squamous cell carcinoma antigen (SCC-Ag) 4 ng/mL (p 0.001) and disease-free int
Like
Comment
Share
